Xenetic and Serum Institute of India quash rift suggestion
This article was originally published in Scrip
Executive Summary
Serum Institute of India has denied any intent to divest its holding in Xenetic Biosciences, formerly known as Lipoxen, adding that its commitment to the UK-based firm will continue on a "long-term basis".